Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

differentiated thyroid carcinoma News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A prospective study compares [⁶⁸Ga]Ga-CTR-FAPI and [⁶⁸Ga]Ga-FAPI-04 PET/CT imaging for evaluating patients with radioiodine-refractory differentiated thyroid cancer. The findings may enhance diagnostic approaches in this challenging patient population.

A recent study evaluates the effectiveness of radioiodine therapy in managing pediatric differentiated thyroid cancer, suggesting that a less aggressive approach may be beneficial. This research could influence treatment protocols for this rare cancer in children.

A study involving 10,504 patients examines long-term outcomes of locoregional recurrence after transaxillary robotic thyroidectomy for differentiated thyroid cancer. The findings contribute to understanding surgical impacts on recurrence rates in this patient population.

The updated Dutch 2026 guidelines for pediatric differentiated thyroid carcinoma align with European standards, enhancing treatment protocols. This update reflects ongoing efforts to standardize care across regions for this rare cancer.

A new graded prognostic assessment for brain metastases in differentiated thyroid carcinoma has been developed and validated using data from over 10,000 patients. This tool aims to improve patient stratification and treatment planning.

Not rare diseases news,news about your rare disease.

Earlier

A prospective study compares [⁶⁸Ga]Ga-CTR-FAPI and [⁶⁸Ga]Ga-FAPI-04 PET/CT imaging for evaluating patients with radioiodine-refractory differentiated thyroid cancer. The findings may enhance diagnostic approaches in this challenging patient population.

A recent study evaluates the effectiveness of radioiodine therapy in managing pediatric differentiated thyroid cancer, suggesting that a less aggressive approach may be beneficial. This research could influence treatment protocols for this rare cancer in children.

A study involving 10,504 patients examines long-term outcomes of locoregional recurrence after transaxillary robotic thyroidectomy for differentiated thyroid cancer. The findings contribute to understanding surgical impacts on recurrence rates in this patient population.

The updated Dutch 2026 guidelines for pediatric differentiated thyroid carcinoma align with European standards, enhancing treatment protocols. This update reflects ongoing efforts to standardize care across regions for this rare cancer.

A new graded prognostic assessment for brain metastases in differentiated thyroid carcinoma has been developed and validated using data from over 10,000 patients. This tool aims to improve patient stratification and treatment planning.

Not rare diseases news,
news about your rare disease.